SE8104236L - 3-aminoproxifenylderivat, deras framstellning och lekemedel innehallande dessa - Google Patents

3-aminoproxifenylderivat, deras framstellning och lekemedel innehallande dessa

Info

Publication number
SE8104236L
SE8104236L SE8104236D SE8104236D SE8104236L SE 8104236 L SE8104236 L SE 8104236L SE 8104236 D SE8104236 D SE 8104236D SE 8104236 D SE8104236 D SE 8104236D SE 8104236 L SE8104236 L SE 8104236L
Authority
SE
Sweden
Prior art keywords
aminoproxifenyl
derivatives
preparation
medicines containing
medicines
Prior art date
Application number
SE8104236D
Other languages
English (en)
Swedish (sv)
Inventor
W J Louis
R Berthold
A Stoll
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE8104236L publication Critical patent/SE8104236L/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
    • C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/53—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and hydroxy groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/24—Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8104236D 1980-07-09 1981-07-07 3-aminoproxifenylderivat, deras framstellning och lekemedel innehallande dessa SE8104236L (sv)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB8022412 1980-07-09
CH599980 1980-08-07
CH824780 1980-11-06
CH824580 1980-11-06
GB8041155 1980-12-23
GB8104585 1981-02-13

Publications (1)

Publication Number Publication Date
SE8104236L true SE8104236L (sv) 1982-01-10

Family

ID=27543773

Family Applications (2)

Application Number Title Priority Date Filing Date
SE8104236A SE457255B (sv) 1980-07-09 1981-07-07 3-aminoproxifenylderivat, deras framstaellning och laekemedel innehaallande dessa
SE8104236D SE8104236L (sv) 1980-07-09 1981-07-07 3-aminoproxifenylderivat, deras framstellning och lekemedel innehallande dessa

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE8104236A SE457255B (sv) 1980-07-09 1981-07-07 3-aminoproxifenylderivat, deras framstaellning och laekemedel innehaallande dessa

Country Status (11)

Country Link
US (2) US4816604A (it)
AU (1) AU547666B2 (it)
DE (1) DE3125870C2 (it)
FR (1) FR2489316B1 (it)
GB (1) GB2132611B (it)
IL (1) IL63245A (it)
IT (1) IT1171374B (it)
NZ (1) NZ197632A (it)
PH (1) PH22546A (it)
SE (2) SE457255B (it)
WO (1) WO1982000141A1 (it)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1262729A (en) * 1983-10-19 1989-11-07 Leo Alig Phenoxypropanolamines
DE3907512C2 (de) * 1989-03-08 1997-08-14 Laevosan Gmbh & Co Kg Neue Aryloxy-alkylamine, deren Herstellung und diese enthaltende Arzneimittel
US5304367A (en) * 1990-11-16 1994-04-19 New York University In vivo brain imaging agent and method for diagnosis of psychiatric disorders
US5217994A (en) * 1991-08-09 1993-06-08 Merck & Co., Inc. Method of inhibiting osteoclast-mediated bone resorption by administration of aminoalkyl-substituted phenyl derivatives
ATE185070T1 (de) * 1992-05-22 1999-10-15 Senju Pharma Co Arzneimittel gegen glaukom
WO1997013744A1 (en) * 1995-10-10 1997-04-17 The University Of Melbourne 3-amino-propoxyphenyl derivatives (i)
EP2590937A1 (en) 2010-07-05 2013-05-15 The University Of Nottingham Phenoxypropanol derivatives and their use in treating cardiac and cardiovascular diseases
GB201101959D0 (en) * 2011-02-04 2011-03-23 Univ Nottingham Novel ether linked compoundsand improved treatments for cardiac and cardiovascular disease

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1957706C3 (de) * 1968-11-18 1978-06-29 Pfizer Corp., Colon (Panama) Kernsubstituierte 3-Phenoxy-l-phenoxyalkylamino-propan-2-ole und Arzneimittel auf deren Basis
DE2023829C3 (de) * 1970-05-15 1979-06-21 Pfizer Corp., Colon (Panama) Kernsubstituierte 3-Phenoxy-lphenoxyalkyl-amino-propan-2-oIe, Verfahren zu ihrer Herstellung sowie Arzneimittel
AR204726A1 (es) * 1973-01-17 1976-02-27 Ciba Geigy Ag Procedimiento para la preparacion de 1-(4-(alquiltio-alcoxi)-fenoxil)-2-hidroxi-3-alquilaminopropano
ZA741812B (en) * 1973-04-18 1975-04-30 Haessle A New amines and process for their preparation
ZA754241B (en) * 1974-11-01 1976-06-30 Haessle Ab New amines
DE2549745A1 (de) * 1974-11-20 1976-05-26 Lipha Durch einen chromonylrest substituierte propionsaeuren sowie deren derivate und verwendungen
FR2330383A1 (fr) * 1975-11-06 1977-06-03 Synthelabo Nouveaux ethers de phenols substitues, leurs sels, leur preparation et les medicaments qui les renferment
DE2606140A1 (de) * 1976-02-17 1977-08-25 Boehringer Sohn Ingelheim Neue derivate des 2-phenyl-2-hydroxyaethylamins
DE2614875C2 (de) * 1976-04-06 1978-06-15 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von Alkyl- bzw. Arylthiomethylphenolen
DE2645710C2 (de) * 1976-10-09 1985-06-27 Merck Patent Gmbh, 6100 Darmstadt Phenoxy-amino-propanole, Verfahren zu ihrer Herstellung und pharmazeutische Zubereitung
FR2368951A2 (fr) * 1976-10-27 1978-05-26 Synthelabo Nouveaux ethers de phenol
JPS6022701B2 (ja) * 1977-06-02 1985-06-03 ウェルファイド株式会社 フエノキシアミノプロパノ−ル誘導体およびその製法
SE7807408L (sv) * 1978-06-30 1979-12-31 Haessle Ab Hjertaktiva foreningar
US4294966A (en) * 1978-07-28 1981-10-13 Ciba-Geigy Corporation Process for inverting the configuration in optically active compounds
DE2838273A1 (de) * 1978-09-01 1980-03-13 Bayer Ag Verfahren zur herstellung von alkyl- bzw. arylthiomethylphenolen
ZW9881A1 (en) * 1980-06-02 1981-12-23 Hoffmann La Roche Substituted phenoxyaminopropanol derivatives

Also Published As

Publication number Publication date
GB2132611A (en) 1984-07-11
IL63245A0 (en) 1981-10-30
US4970238A (en) 1990-11-13
DE3125870A1 (de) 1982-03-25
DE3125870C2 (de) 1994-09-15
IT1171374B (it) 1987-06-10
SE457255B (sv) 1988-12-12
IT8148859A0 (it) 1981-07-08
FR2489316B1 (it) 1985-01-18
NZ197632A (en) 1984-07-31
AU547666B2 (en) 1985-10-31
GB8324990D0 (en) 1983-10-19
IL63245A (en) 1985-06-30
WO1982000141A1 (en) 1982-01-21
GB2132611B (en) 1985-01-16
AU7263081A (en) 1982-01-14
FR2489316A1 (it) 1982-03-05
PH22546A (en) 1988-10-17
US4816604A (en) 1989-03-28

Similar Documents

Publication Publication Date Title
FI822005A0 (fi) Antifungisida aemnen, foerfarande foer deras framstaellning, och dessa innehaollande farmaceutiska sammansaettningar
FI813852L (fi) 1-sulfo-2-oxoazetidinderivat deras framstaellning och anvaendning
DK499081A (da) Kornformig laegemiddel-retardform
PT73686A (pt) Pharmaceutical formulation
DE3480599D1 (de) 1-hydroxypyrid-2-on-derivate enthaltende pharmazeutische zubereitungen.
FI822164A0 (fi) Cylinderlaos-nyckelkombination, laoscylinder och nyckel foer denna kombination
FI792009A (fi) 3-aminopropoxiarylderivat deras framstaellning och dessa innehaollande farmaceutiska sammansaettningar
FI812810L (fi) Ammoniometylfoereningar farmaceutiska preparat innehaollande dessa foereningar och anvaendning av sistnaemnda
FI811936L (fi) Arrangemang foer bestaemmande och observering av gashalter i blodet av en patient
FI823544A0 (fi) Triazinderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar
FI831271A0 (fi) Saett och anordning foer sortering av emballage
FI812811L (fi) N-oxider av n-oxacyklyl-alkylpiperidiner foerfarande foer deras framstaellning dessa foereningar innehaollande farmaceutiska preparat och deras anvaendning
FI810056L (fi) Farmaceutiska foereningar
FI813412L (fi) 3-aminopropoxifenylderivat deras framstaellning och dessa innehaollande farmaceutiska produkter
FI853199L (fi) Farmaceutiska sammansaettningar med tumoermotverkande effekt och foerfarande foer framstaellning av dessa.
SE8104236L (sv) 3-aminoproxifenylderivat, deras framstellning och lekemedel innehallande dessa
FI834061A (fi) 2-piperazinylkinazolinderivat, framstaellning av dem och farmaceutiska kompositioner innehaollande dem
NO811003L (no) Farmasoeytiske preparater.
MC1371A1 (fr) Preparations pharmaceutiques
FI811880L (fi) Farmaceutiska bicykliska foereningar och kompositioner
FI830399L (fi) Mjoeldryge-alkaloider, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska produkter
BE887471A (fr) Derives benzylideniques, leur preparation et leur utilisation
FI822980A0 (fi) Furanokromonderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska produkter
SE448090B (sv) Tiokarnitiner och farmaceutiska kompositioner som innehaller dessa
FI812253L (fi) Ergolinderivat foerfarande foer deras framstaellning dessa innehaollande farmaceutiska foereningar och deras anvaendning vid terapeutisk behandling

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8104585-8